These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 12673089

  • 1. Treatment of Old World cutaneous leishmaniasis with intralesionally injected meglumine antimoniate using a Dermojet device.
    Bogenrieder T, Lehn N, Landthaler M, Stolz W.
    Dermatology; 2003; 206(3):269-72. PubMed ID: 12673089
    [Abstract] [Full Text] [Related]

  • 2. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
    Moosavi Z, Nakhli A, Rassaii S.
    Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
    [No Abstract] [Full Text] [Related]

  • 3. Allopurinol in the treatment of American cutaneous leishmaniasis.
    Martinez S, Marr JJ.
    N Engl J Med; 1992 Mar 12; 326(11):741-4. PubMed ID: 1738379
    [Abstract] [Full Text] [Related]

  • 4. Intralesional treatment with meglumine antimoniate in three patients with New World cutaneous leishmaniasis and large periarticular lesions with comorbidities.
    Pimentel MIF, Vasconcellos ÉCFE, Ribeiro CO, Lyra MR, Saheki MN, Salgueiro MM, Antonio LF, Schubach AO.
    Rev Soc Bras Med Trop; 2017 Mar 12; 50(2):269-272. PubMed ID: 28562769
    [Abstract] [Full Text] [Related]

  • 5. Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis.
    Salmanpour R, Razmavar MR, Abtahi N.
    Int J Dermatol; 2006 Sep 12; 45(9):1115-6. PubMed ID: 16961529
    [No Abstract] [Full Text] [Related]

  • 6. Clinical efficacy of intramuscular meglumine antimoniate alone and in combination with intralesional meglumine antimoniate in the treatment of old world cutaneous leishmaniasis.
    Munir A, Janjua SA, Hussain I.
    Acta Dermatovenerol Croat; 2008 Sep 12; 16(2):60-4. PubMed ID: 18541100
    [Abstract] [Full Text] [Related]

  • 7. Standardization of intralesional meglumine antimoniate treatment for cutaneous leishmaniasis.
    Duque MC, Vasconcellos ÉC, Pimentel MI, Lyra MR, Pacheco SJ, Marzochi MC, Rosalino CM, Schubach AO.
    Rev Soc Bras Med Trop; 2016 Sep 12; 49(6):774-776. PubMed ID: 28001228
    [Abstract] [Full Text] [Related]

  • 8. Effects of antimonial therapy for canine leishmaniasis on antibody titer.
    Amusategui I, Sainz A, Tesouro MA.
    Ann N Y Acad Sci; 1998 Jun 29; 849():444-6. PubMed ID: 9668509
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of intralesionally injected zinc sulfate with meglumine antimoniate in the treatment of acute cutaneous leishmaniasis.
    Iraji F, Vali A, Asilian A, Shahtalebi MA, Momeni AZ.
    Dermatology; 2004 Jun 29; 209(1):46-9. PubMed ID: 15237267
    [Abstract] [Full Text] [Related]

  • 10. Intralesional treatment of cutaneous leishmaniasis with meglumine antimoniate.
    Aste N, Pau M, Ferreli C, Biggio P.
    Br J Dermatol; 1998 Feb 29; 138(2):370-1. PubMed ID: 9602904
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of Intralesional Sodium Stibogluconate versus Intralesional Meglumine Antimoniate for the Treatment of Leishmania major Cutaneous Leishmaniasis.
    Solomon M, Ollech A, Pavlotsky F, Barzilai A, Schwartz E, Baum S, Astman N.
    Acta Derm Venereol; 2024 Apr 29; 104():adv35089. PubMed ID: 38682801
    [Abstract] [Full Text] [Related]

  • 12. Treatment of acute cutaneous leishmaniasis with intralesional injection of meglumine antimoniate: comparison of conventional technique with mesotherapy gun.
    Kashani MN, Sadr B, Nilforoushzadeh MA, Arasteh M, Babakoohi S, Firooz A.
    Int J Dermatol; 2010 Sep 29; 49(9):1034-7. PubMed ID: 20883265
    [Abstract] [Full Text] [Related]

  • 13. Resistance to antimony and treatment failure in human Leishmania (Viannia) infection.
    Rojas R, Valderrama L, Valderrama M, Varona MX, Ouellette M, Saravia NG.
    J Infect Dis; 2006 May 15; 193(10):1375-83. PubMed ID: 16619185
    [Abstract] [Full Text] [Related]

  • 14. Treatment of cutaneous leishmaniasis with antimony: intramuscular versus intralesional administration.
    Alkhawajah AM, Larbi E, al-Gindan Y, Abahussein A, Jain S.
    Ann Trop Med Parasitol; 1997 Dec 15; 91(8):899-905. PubMed ID: 9579209
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of CO(2) laser for treatment of anthroponotic cutaneous leishmaniasis, compared with combination of cryotherapy and intralesional meglumine antimoniate.
    Shamsi Meymandi S, Zandi S, Aghaie H, Heshmatkhah A.
    J Eur Acad Dermatol Venereol; 2011 May 15; 25(5):587-91. PubMed ID: 20666876
    [Abstract] [Full Text] [Related]

  • 16. Successful treatment of non-healing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinol.
    Momeni AZ, Aminjavaheri M.
    Eur J Dermatol; 2003 May 15; 13(1):40-3. PubMed ID: 12609780
    [Abstract] [Full Text] [Related]

  • 17. Weekly vs. fortnightly intralesional meglumine antimoniate in cutaneous leishmaniasis.
    Mujtaba G, Khalid M.
    Int J Dermatol; 1999 Aug 15; 38(8):607-9. PubMed ID: 10487452
    [No Abstract] [Full Text] [Related]

  • 18. Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy.
    Shamsi Meymandi S, Javadi A, Dabiri S, Shamsi Meymandi M, Nadji M.
    Arch Iran Med; 2011 Jul 15; 14(4):238-43. PubMed ID: 21726098
    [Abstract] [Full Text] [Related]

  • 19. The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis.
    Asilian A, Sadeghinia A, Faghihi G, Momeni A, Amini Harandi A.
    Ann Trop Med Parasitol; 2003 Jul 15; 97(5):493-8. PubMed ID: 12930612
    [Abstract] [Full Text] [Related]

  • 20. Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey.
    Uzun S, Durdu M, Culha G, Allahverdiyev AM, Memisoglu HR.
    J Parasitol; 2004 Aug 15; 90(4):853-9. PubMed ID: 15357081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.